輸液バッグの世界市場 2024-2028

輸液バッグ市場は2023-2028年に8億4,608万米ドル、予測期間中のCAGRは6.01％で成長すると予測されます。

当レポートでは、輸液バッグ市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、慢性疾患の増加、世界の高齢化、世界の政府・憲法機関によるヘルスケア支出の増加によって牽引されています。

本調査では、今後数年間の輸液バッグ市場の成長を牽引する主な要因の1つとして、材料技術の革新と進歩を挙げています。また、シングルユースと無菌性への注目の高まり、在宅ヘルスケアと外来環境での採用の増加は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 輸液バッグの世界市場 2018-2022
• タイプセグメント分析 2018-2022
• エンドユーザーセグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• PVC素材：市場規模と予測 2023-2028
• 非PVC素材：市場規模と予測 2023-2028
• 市場機会：タイプ別

第7章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 病院：市場規模と予測 2023-2028
• 在宅ヘルスケア：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：エンドユーザー別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 日本：市場規模と予測 2023-2028
• フランス：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Alfa Laboratories SAL
• B.Braun SE
• Baxter International Inc.
• DL Chemical
• Fosmo Med
• Fresenius SE and Co. KGaA
• ICU Medical Inc.
• Otsuka Holdings Co. Ltd.
• Pharmaceutical Solutions Industry
• RENOLIT SE
• SIPPEX
• Technoflex
• The Metrix Co.
• Vioser SA
• Wellpharma

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global intravenous fluid bags market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on PVC material - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on PVC material - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on PVC material - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on PVC material - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Non-PVC material - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Non-PVC material - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Non-PVC material - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Non-PVC material - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Type ($ million)
• Exhibits43: Data Table on Market opportunity by Type ($ million)
• Exhibits44: Chart on End-user - Market share 2023-2028 (%)
• Exhibits45: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits46: Chart on Comparison by End-user
• Exhibits47: Data Table on Comparison by End-user
• Exhibits48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibits49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Home healthcare - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Home healthcare - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Home healthcare - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Home healthcare - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits60: Market opportunity by End-user ($ million)
• Exhibits61: Data Table on Market opportunity by End-user ($ million)
• Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits65: Chart on Geographic comparison
• Exhibits66: Data Table on Geographic comparison
• Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits103: Market opportunity By Geographical Landscape ($ million)
• Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits105: Impact of drivers and challenges in 2023 and 2028
• Exhibits106: Overview on Criticality of inputs and Factors of differentiation
• Exhibits107: Overview on factors of disruption
• Exhibits108: Impact of key risks on business
• Exhibits109: Vendors covered
• Exhibits110: Matrix on vendor position and classification
• Exhibits111: Alfa Laboratories SAL - Overview
• Exhibits112: Alfa Laboratories SAL - Product / Service
• Exhibits113: Alfa Laboratories SAL - Key offerings
• Exhibits114: B.Braun SE - Overview
• Exhibits115: B.Braun SE - Business segments
• Exhibits116: B.Braun SE - Key news
• Exhibits117: B.Braun SE - Key offerings
• Exhibits118: B.Braun SE - Segment focus
• Exhibits119: Baxter International Inc. - Overview
• Exhibits120: Baxter International Inc. - Business segments
• Exhibits121: Baxter International Inc. - Key news
• Exhibits122: Baxter International Inc. - Key offerings
• Exhibits123: Baxter International Inc. - Segment focus
• Exhibits124: DL Chemical - Overview
• Exhibits125: DL Chemical - Product / Service
• Exhibits126: DL Chemical - Key offerings
• Exhibits127: Fosmo Med - Overview
• Exhibits128: Fosmo Med - Product / Service
• Exhibits129: Fosmo Med - Key offerings
• Exhibits130: Fresenius SE and Co. KGaA - Overview
• Exhibits131: Fresenius SE and Co. KGaA - Business segments
• Exhibits132: Fresenius SE and Co. KGaA - Key news
• Exhibits133: Fresenius SE and Co. KGaA - Key offerings
• Exhibits134: Fresenius SE and Co. KGaA - Segment focus
• Exhibits135: ICU Medical Inc. - Overview
• Exhibits136: ICU Medical Inc. - Product / Service
• Exhibits137: ICU Medical Inc. - Key offerings
• Exhibits138: Otsuka Holdings Co. Ltd. - Overview
• Exhibits139: Otsuka Holdings Co. Ltd. - Business segments
• Exhibits140: Otsuka Holdings Co. Ltd. - Key offerings
• Exhibits141: Otsuka Holdings Co. Ltd. - Segment focus
• Exhibits142: Pharmaceutical Solutions Industry - Overview
• Exhibits143: Pharmaceutical Solutions Industry - Product / Service
• Exhibits144: Pharmaceutical Solutions Industry - Key offerings
• Exhibits145: RENOLIT SE - Overview
• Exhibits146: RENOLIT SE - Product / Service
• Exhibits147: RENOLIT SE - Key offerings
• Exhibits148: SIPPEX - Overview
• Exhibits149: SIPPEX - Product / Service
• Exhibits150: SIPPEX - Key offerings
• Exhibits151: Technoflex - Overview
• Exhibits152: Technoflex - Product / Service
• Exhibits153: Technoflex - Key offerings
• Exhibits154: The Metrix Co. - Overview
• Exhibits155: The Metrix Co. - Product / Service
• Exhibits156: The Metrix Co. - Key offerings
• Exhibits157: Vioser SA - Overview
• Exhibits158: Vioser SA - Product / Service
• Exhibits159: Vioser SA - Key offerings
• Exhibits160: Wellpharma - Overview
• Exhibits161: Wellpharma - Product / Service
• Exhibits162: Wellpharma - Key offerings
• Exhibits163: Inclusions checklist
• Exhibits164: Exclusions checklist
• Exhibits165: Currency conversion rates for US$
• Exhibits166: Research methodology
• Exhibits167: Validation techniques employed for market sizing
• Exhibits168: Information sources
• Exhibits169: List of abbreviations

The intravenous fluid bags market is forecasted to grow by USD 846.08 mn during 2023-2028, accelerating at a CAGR of 6.01% during the forecast period. The report on the intravenous fluid bags market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, aging population worldwide, and increase in healthcare expenditure by government and constitutional bodies globally.

Technavio's intravenous fluid bags market is segmented as below:

By Type

• PVC material
• Non-PVC material

By End-user

• Hospitals
• Home healthcare
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the innovations and advancements in material technology as one of the prime reasons driving the intravenous fluid bags market growth during the next few years. Also, rising focus on single-use and sterility and increasing adoption of home healthcare and ambulatory settings will lead to sizable demand in the market.

The report on the intravenous fluid bags market covers the following areas:

• Intravenous fluid bags market sizing
• Intravenous fluid bags market forecast
• Intravenous fluid bags market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading intravenous fluid bags market vendors that include Alfa Laboratories SAL, B.Braun SE, Baxter International Inc., Becton Dickinson and Co., DL Chemical, Fosmo Med, Fresenius SE and Co. KGaA, ICU Medical Inc., Macopharma, Medicopack, Otsuka Holdings Co. Ltd., Pharmaceutical Solutions Industry, Polifarma Ilac San ve Tic AS, PolyCine GmbH, RENOLIT SE, Sartorius AG, SIPPEX, Technoflex, The Metrix Co., Vioser SA, Wellpharma, and West Pharmaceutical Services Inc.. Also, the intravenous fluid bags market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global intravenous fluid bags market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global intravenous fluid bags market 2018 - 2022 ($ million)
• 4.2 Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 End-user Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 PVC material - Market size and forecast 2023-2028
• Exhibit 34: Chart on PVC material - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on PVC material - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on PVC material - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on PVC material - Year-over-year growth 2023-2028 (%)
• 6.4 Non-PVC material - Market size and forecast 2023-2028
• Exhibit 38: Chart on Non-PVC material - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Non-PVC material - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Non-PVC material - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Non-PVC material - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Type
• Exhibit 42: Market opportunity by Type ($ million)
• Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
• 7.2 Comparison by End-user
• Exhibit 46: Chart on Comparison by End-user
• Exhibit 47: Data Table on Comparison by End-user
• 7.3 Hospitals - Market size and forecast 2023-2028
• Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• 7.4 Home healthcare - Market size and forecast 2023-2028
• Exhibit 52: Chart on Home healthcare - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Home healthcare - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Home healthcare - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Home healthcare - Year-over-year growth 2023-2028 (%)
• 7.5 Others - Market size and forecast 2023-2028
• Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by End-user
• Exhibit 60: Market opportunity by End-user ($ million)
• Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 China - Market size and forecast 2023-2028
• Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
• Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 Japan - Market size and forecast 2023-2028
• Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.11 France - Market size and forecast 2023-2028
• Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Alfa Laboratories SAL
• Exhibit 111: Alfa Laboratories SAL - Overview
• Exhibit 112: Alfa Laboratories SAL - Product / Service
• Exhibit 113: Alfa Laboratories SAL - Key offerings
• 12.4 B.Braun SE
• Exhibit 114: B.Braun SE - Overview
• Exhibit 115: B.Braun SE - Business segments
• Exhibit 116: B.Braun SE - Key news
• Exhibit 117: B.Braun SE - Key offerings
• Exhibit 118: B.Braun SE - Segment focus
• 12.5 Baxter International Inc.
• Exhibit 119: Baxter International Inc. - Overview
• Exhibit 120: Baxter International Inc. - Business segments
• Exhibit 121: Baxter International Inc. - Key news
• Exhibit 122: Baxter International Inc. - Key offerings
• Exhibit 123: Baxter International Inc. - Segment focus
• 12.6 DL Chemical
• Exhibit 124: DL Chemical - Overview
• Exhibit 125: DL Chemical - Product / Service
• Exhibit 126: DL Chemical - Key offerings
• 12.7 Fosmo Med
• Exhibit 127: Fosmo Med - Overview
• Exhibit 128: Fosmo Med - Product / Service
• Exhibit 129: Fosmo Med - Key offerings
• 12.8 Fresenius SE and Co. KGaA
• Exhibit 130: Fresenius SE and Co. KGaA - Overview
• Exhibit 131: Fresenius SE and Co. KGaA - Business segments
• Exhibit 132: Fresenius SE and Co. KGaA - Key news
• Exhibit 133: Fresenius SE and Co. KGaA - Key offerings
• Exhibit 134: Fresenius SE and Co. KGaA - Segment focus
• 12.9 ICU Medical Inc.
• Exhibit 135: ICU Medical Inc. - Overview
• Exhibit 136: ICU Medical Inc. - Product / Service
• Exhibit 137: ICU Medical Inc. - Key offerings
• 12.10 Otsuka Holdings Co. Ltd.
• Exhibit 138: Otsuka Holdings Co. Ltd. - Overview
• Exhibit 139: Otsuka Holdings Co. Ltd. - Business segments
• Exhibit 140: Otsuka Holdings Co. Ltd. - Key offerings
• Exhibit 141: Otsuka Holdings Co. Ltd. - Segment focus
• 12.11 Pharmaceutical Solutions Industry
• Exhibit 142: Pharmaceutical Solutions Industry - Overview
• Exhibit 143: Pharmaceutical Solutions Industry - Product / Service
• Exhibit 144: Pharmaceutical Solutions Industry - Key offerings
• 12.12 RENOLIT SE
• Exhibit 145: RENOLIT SE - Overview
• Exhibit 146: RENOLIT SE - Product / Service
• Exhibit 147: RENOLIT SE - Key offerings
• 12.13 SIPPEX
• Exhibit 148: SIPPEX - Overview
• Exhibit 149: SIPPEX - Product / Service
• Exhibit 150: SIPPEX - Key offerings
• 12.14 Technoflex
• Exhibit 151: Technoflex - Overview
• Exhibit 152: Technoflex - Product / Service
• Exhibit 153: Technoflex - Key offerings
• 12.15 The Metrix Co.
• Exhibit 154: The Metrix Co. - Overview
• Exhibit 155: The Metrix Co. - Product / Service
• Exhibit 156: The Metrix Co. - Key offerings
• 12.16 Vioser SA
• Exhibit 157: Vioser SA - Overview
• Exhibit 158: Vioser SA - Product / Service
• Exhibit 159: Vioser SA - Key offerings
• 12.17 Wellpharma
• Exhibit 160: Wellpharma - Overview
• Exhibit 161: Wellpharma - Product / Service
• Exhibit 162: Wellpharma - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 163: Inclusions checklist
• Exhibit 164: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 165: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 166: Research methodology
• Exhibit 167: Validation techniques employed for market sizing
• Exhibit 168: Information sources
• 13.5 List of abbreviations
• Exhibit 169: List of abbreviations